Nuvilex, Inc. Diabetes Studies Could Eliminate Need for Daily Insulin Requirements

[Northerner]

When investors look into biotechnology and pharmaceutical companies as an investment opportunity, three areas of research stand out as the most favorable for future returns. The big three are cancer, heart disease and diabetes research that can eventually lead to corresponding clinical trials. Well, Nuvilex, Inc. (otcqb:NVLX) is currently involved in 2 of the 3 -- cancer and diabetes.

While Nuvilex prepares for a large-scale, late-phase clinical trial studying its treatment for patients with advanced, inoperable pancreatic cancer, the company is also using the same basic technology to study diabetes. That technology is a unique and proprietary living cell encapsulation process, and the good news for those with diabetes is the basic technology has delivered astounding results in the company's pancreatic cancer trials.

http://www.marketwatch.com/story/nu...eed-for-daily-insulin-requirements-2013-03-18

 

[trophywench]

There was a report last week about someone doing this - the one where they were gonna transplant the capsule in the abdomen - so looks like the race is on.